Jawaid Akbar Sial
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jawaid Akbar Sial has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Tahir Saghir
National Institute of Cardiovascular Diseases, Karachi, Pakistan
12 shared publications - Musa Karim
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
10 shared publications - Nadeem Qamar
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
7 shared publications - Rajesh Kumar
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
7 shared publications - Ali Ammar
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
5 shared publications - Jehangir Ali Shah
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
4 shared publications
Latest Publications
- Open Access
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 139-146
Significance of On-admission Impaired Estimated Glomerular Filtration Rate for the Assessment of Immediate Outcomes after Percutaneous Coronary Intervention
Objectives: Impaired baseline estimated glomerular filtration rate (eGFR) has been associated with a heightened risk of major adverse clinical events (MACE) following percutaneous coronary intervention (PCI). Early recognition of renal dysfunction on admission can help optimize clinical decision-making and improve post-PCI outcomes. This study aimed to evaluate the prognostic significance of baseline eGFR among patients with acute myocardial infarction (AMI) and its impact on immediate in-hospital outcomes after PCI. Methodology: We enrolled adult AMI patients undergoing PCI and calculated their baseline eGFR (ml/min/1.73 m²). In-hospital MACE was recorded for all patients. Participants were stratified into three groups based on eGFR values: ≥60, 45–59, and <45 ml/min/1.73 m². Results: Among 296 patients (mean age: 56.8 ± 10.8 years; 87.5% male), eGFR distribution was as follows: ≥60 in 75.3%, 45–59 in 12.8%, and <45 in 11.8%. Overall, MACE occurred in 5.7% (17 patients). The incidence of MACE was significantly higher in patients with reduced eGFR (p=0.005), observed in 3.6% of patients with eGFR ≥ 60, 7.9% with eGFR 45–59, and 17.1% with eGFR <45. In multivariable analysis, Killip class III or IV and final TIMI (thrombolysis in myocardial infarction) flow < III were identified as independent predictors of in-hospital MACE (adjusted odds ratios [ORs]: 3.81 [95% confidence interval (CI): 1.01–14.36] and 7.17 [95% CI: 2.08–24.68], respectively), while eGFR did not reach statistical significance. Conclusion: Reduced baseline eGFR was associated with a higher incidence of in-hospital MACE following PCI in AMI patients. However, after adjusting for confounders, Killip class III or IV and suboptimal final TIMI flow were more robust independent predictors of immediate adverse outcomes. Methodology: We enrolled adult AMI patients undergoing PCI and calculated their baseline eGFR (ml/min/1.73 m²). In-hospital MACE was recorded for all patients. Participants were stratified into three groups based on eGFR values: ≥60, 45–59, and <45 ml/min/1.73 m². Results: Among 296 patients (mean age: 56.8 ± 10.8 years; 87.5% male), eGFR distribution was as follows: ≥60 in 75.3%, 45–59 in 12.8%, and <45 in 11.8%. Overall, MACE occurred in 5.7% (17 patients). The incidence of MACE was significantly higher in patients with reduced eGFR (p=0.005), observed in 3.6% of patients with eGFR ≥ 60, 7.9% with eGFR 45–59, and 17.1% with eGFR <45. In multivariable analysis, Killip class III or IV and final TIMI (thrombolysis in myocardial infarction) flow < III were identified as independent predictors of in-hospital MACE (adjusted odds ratios [ORs]: 3.81 [95% confidence interval (CI): 1.01–14.36] and 7.17 [95% CI: 2.08–24.68], respectively), while eGFR did not reach statistical significance. Conclusion: Reduced baseline eGFR was associated with a higher incidence of in-hospital MACE following PCI in AMI patients. However, after adjusting for confounders, Killip class III or IV and suboptimal final TIMI flow were more robust independent predictors of immediate adverse outcomes.
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 139-146
Open AccessSignificance of On-admission Impaired Estimated Glomerular Filtration Rate for the Assessment of Immediate Outcomes after Percutaneous Coronary Intervention
Objectives: Impaired baseline estimated glomerular filtration rate (eGFR) has been associated with a heightened risk of major adverse clinical events (MACE) following percutaneous coronary intervention (PCI). Early recognition of renal dysfunction on admission can help optimize clinical decision-making and improve post-PCI outcomes. This study aimed to evaluate the prognostic significance of baseline eGFR among patients with acute myocardial infarction (AMI) and its impact on immediate in-hospital outcomes after PCI. Methodology: We enrolled adult AMI patients undergoing PCI and calculated their baseline eGFR (ml/min/1.73 m²). In-hospital MACE was recorded for all patients. Participants were stratified into three groups based on eGFR values: ≥60, 45–59, and <45 ml/min/1.73 m². Results: Among 296 patients (mean age: 56.8 ± 10.8 years; 87.5% male), eGFR distribution was as follows: ≥60 in 75.3%, 45–59 in 12.8%, and <45 in 11.8%. Overall, MACE occurred in 5.7% (17 patients). The incidence of MACE was significantly higher in patients with reduced eGFR (p=0.005), observed in 3.6% of patients with eGFR ≥ 60, 7.9% with eGFR 45–59, and 17.1% with eGFR <45. In multivariable analysis, Killip class III or IV and final TIMI (thrombolysis in myocardial infarction) flow < III were identified as independent predictors of in-hospital MACE (adjusted odds ratios [ORs]: 3.81 [95% confidence interval (CI): 1.01–14.36] and 7.17 [95% CI: 2.08–24.68], respectively), while eGFR did not reach statistical significance. Conclusion: Reduced baseline eGFR was associated with a higher incidence of in-hospital MACE following PCI in AMI patients. However, after adjusting for confounders, Killip class III or IV and suboptimal final TIMI flow were more robust independent predictors of immediate adverse outcomes. Methodology: We enrolled adult AMI patients undergoing PCI and calculated their baseline eGFR (ml/min/1.73 m²). In-hospital MACE was recorded for all patients. Participants were stratified into three groups based on eGFR values: ≥60, 45–59, and <45 ml/min/1.73 m². Results: Among 296 patients (mean age: 56.8 ± 10.8 years; 87.5% male), eGFR distribution was as follows: ≥60 in 75.3%, 45–59 in 12.8%, and <45 in 11.8%. Overall, MACE occurred in 5.7% (17 patients). The incidence of MACE was significantly higher in patients with reduced eGFR (p=0.005), observed in 3.6% of patients with eGFR ≥ 60, 7.9% with eGFR 45–59, and 17.1% with eGFR <45. In multivariable analysis, Killip class III or IV and final TIMI (thrombolysis in myocardial infarction) flow < III were identified as independent predictors of in-hospital MACE (adjusted odds ratios [ORs]: 3.81 [95% confidence interval (CI): 1.01–14.36] and 7.17 [95% CI: 2.08–24.68], respectively), while eGFR did not reach statistical significance. Conclusion: Reduced baseline eGFR was associated with a higher incidence of in-hospital MACE following PCI in AMI patients. However, after adjusting for confounders, Killip class III or IV and suboptimal final TIMI flow were more robust independent predictors of immediate adverse outcomes.
- Open Access
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 194-199
Early Outcomes of the First 500 Cardiac Surgeries at a Newly Established Rural Cardiac Centre in Pakistan: A Retrospective Observational Study
Objectives: To evaluate early surgical outcomes, safety, and perioperative complications among the first 500 cardiac surgeries performed at a newly established rural cardiac center in Larkana. Methodology: This retrospective observational study included the first 500 consecutive cardiovascular surgeries performed at SICVD, Larkana, between December 2018 and August 2024. Patients undergoing coronary, valvular, and congenital cardiac surgeries were included. Operative risk was assessed using the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II). Early postoperative outcomes, including 7-day mortality and major complications, were analyzed using descriptive statistics. Results: The mean age of the cohort was 49.39 ± 13.05 years, with a male predominance of 72.6%. Smoking (48%), hypertension (34.6%), and diabetes mellitus (26.2%) were the most prevalent risk factors. Coronary artery bypass grafting constituted the majority of procedures (75.6%). The overall 7-day mortality rate was 1.8%, while isolated CABG was associated with a mortality rate of 1.5%. Postoperative complication rates remained low across procedure categories. Conclusion: The early experience from this rural cardiac center demonstrates that safe and effective cardiac surgical care can be delivered in underserved settings when supported by adequate infrastructure, funding, and a trained multidisciplinary team. These findings support the expansion of decentralized cardiac services to improve equitable access to care.
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 194-199
Open AccessEarly Outcomes of the First 500 Cardiac Surgeries at a Newly Established Rural Cardiac Centre in Pakistan: A Retrospective Observational Study
Objectives: To evaluate early surgical outcomes, safety, and perioperative complications among the first 500 cardiac surgeries performed at a newly established rural cardiac center in Larkana. Methodology: This retrospective observational study included the first 500 consecutive cardiovascular surgeries performed at SICVD, Larkana, between December 2018 and August 2024. Patients undergoing coronary, valvular, and congenital cardiac surgeries were included. Operative risk was assessed using the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II). Early postoperative outcomes, including 7-day mortality and major complications, were analyzed using descriptive statistics. Results: The mean age of the cohort was 49.39 ± 13.05 years, with a male predominance of 72.6%. Smoking (48%), hypertension (34.6%), and diabetes mellitus (26.2%) were the most prevalent risk factors. Coronary artery bypass grafting constituted the majority of procedures (75.6%). The overall 7-day mortality rate was 1.8%, while isolated CABG was associated with a mortality rate of 1.5%. Postoperative complication rates remained low across procedure categories. Conclusion: The early experience from this rural cardiac center demonstrates that safe and effective cardiac surgical care can be delivered in underserved settings when supported by adequate infrastructure, funding, and a trained multidisciplinary team. These findings support the expansion of decentralized cardiac services to improve equitable access to care.
- Open Access
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 162-169
Prevalence and Clinical Associations of Myocardial Bridging in Patients Undergoing Coronary Angiography at a Tertiary Care Center in Pakistan
Objectives: To determine the prevalence of myocardial bridging and describe its angiographic distribution, demographic profile, and associated clinical characteristics among patients undergoing coronary angiography at a tertiary cardiac center in Pakistan. Methodology: This descriptive cross-sectional study was conducted at the Adult Cardiology Department of the National Institute of Cardiovascular Diseases (NICVD), Karachi, from 16 June to 16 July 2025. A total of 1003 consecutive adult patients (≥18 years) undergoing coronary angiography were enrolled using non-probability consecutive sampling. Patients with prior coronary artery bypass grafting or who declined consent were excluded. Demographic, clinical, and angiographic data were collected using a structured proforma. Myocardial bridging was identified using standard angiographic criteria and confirmed by independent cardiologist review. Multivariable logistic regression was performed to evaluate associations with MB detection. Results: Myocardial bridging was identified in 58 patients (5.78%). The mean age of MB patients was 58 ± 10.3 years, and 82.8% were male. The LAD was involved in 98.3% of cases, predominantly the mid-LAD segment (84.5%). Only 15.5% of MB patients were symptomatic. Atherosclerosis was present in 63.8% of cases, mainly proximal to the bridged segment, with no plaque within the tunneled segment. Age >65 years was associated with higher odds of MB detection, while diabetes mellitus and family history of coronary artery disease were associated with lower odds. Conclusion: Myocardial bridging was observed in approximately 6% of angiography patients, most often involving the mid-LAD and detected incidentally. These findings reflect detection patterns within an angiography-referred population.
- 28 February 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (1) , 162-169
Open AccessPrevalence and Clinical Associations of Myocardial Bridging in Patients Undergoing Coronary Angiography at a Tertiary Care Center in Pakistan
Objectives: To determine the prevalence of myocardial bridging and describe its angiographic distribution, demographic profile, and associated clinical characteristics among patients undergoing coronary angiography at a tertiary cardiac center in Pakistan. Methodology: This descriptive cross-sectional study was conducted at the Adult Cardiology Department of the National Institute of Cardiovascular Diseases (NICVD), Karachi, from 16 June to 16 July 2025. A total of 1003 consecutive adult patients (≥18 years) undergoing coronary angiography were enrolled using non-probability consecutive sampling. Patients with prior coronary artery bypass grafting or who declined consent were excluded. Demographic, clinical, and angiographic data were collected using a structured proforma. Myocardial bridging was identified using standard angiographic criteria and confirmed by independent cardiologist review. Multivariable logistic regression was performed to evaluate associations with MB detection. Results: Myocardial bridging was identified in 58 patients (5.78%). The mean age of MB patients was 58 ± 10.3 years, and 82.8% were male. The LAD was involved in 98.3% of cases, predominantly the mid-LAD segment (84.5%). Only 15.5% of MB patients were symptomatic. Atherosclerosis was present in 63.8% of cases, mainly proximal to the bridged segment, with no plaque within the tunneled segment. Age >65 years was associated with higher odds of MB detection, while diabetes mellitus and family history of coronary artery disease were associated with lower odds. Conclusion: Myocardial bridging was observed in approximately 6% of angiography patients, most often involving the mid-LAD and detected incidentally. These findings reflect detection patterns within an angiography-referred population.
- Open Access
- 1 January 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 58 (4) , 353-358
Clinical Predictors of Revascularization in Patients with Aborted Myocardial Infarction
Objectives: The objective of this study was to evaluate the clinical and angiographic profiles of patients with aborted myocardial infarction (MI) and to identify the revascularization strategy for these patients. Methodology: A total of 120 consecutive patients with aborted MI, undergoing immediate revascularization at a tertiary care cardiac center, were included in the study. Aborted MI was defined as the spontaneous resolution of ST-segment elevation by >70% on consecutive ECGs before the administration of definitive reperfusion therapy. Patients were categorized into two groups: reperfusion therapy (RT) and recanalized vessels (RV) group. The RT group included patients who underwent plain old balloon angioplasty (POBA) or stent deployment. Results: Among the 120 patients, 85.8% (103) were male, with a mean age of 48.91±11.62 years. Recanalized vessels were observed in 36.7% (44) of the patients. Compared to the RT group, patients in the RV group were relatively younger (43.41±12.68 vs. 52.09±9.7 years; p<0.001). A significantly higher proportion of patients in the RV group had anterior wall MI (AWMI) (67.1% vs. 9.5%; p<0.001) and a shorter median chest pain-to-ACS protocol time (180 [120-255] vs. 300 [180-360] minutes; p=0.003). Multivariable regression analysis identified AWMI as an independent predictor of the need for immediate revascularization, with an adjusted odds ratio of 5.74 [95% CI: 2.33-14.16]. Conclusion: Our study concludes that patients with aborted MI can be classified based on their clinical profiles to determine the timing and strategy of revascularization. Patients were categorized into two groups: those with recanalized vessels (RV) on angiography and those requiring revascularization therapy (RT), either POBA or stent deployment. Several predictors, such as younger age at presentation, type 2 diabetes mellitus, smoking, family history of premature coronary artery disease, dyslipidemia, and the time elapsed after chest pain onset, can help pre-classify patients into high-risk categories requiring immediate revascularization or low-risk categories eligible for early invasive strategies.
- 1 January 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 58 (4) , 353-358
Open AccessClinical Predictors of Revascularization in Patients with Aborted Myocardial Infarction
Objectives: The objective of this study was to evaluate the clinical and angiographic profiles of patients with aborted myocardial infarction (MI) and to identify the revascularization strategy for these patients. Methodology: A total of 120 consecutive patients with aborted MI, undergoing immediate revascularization at a tertiary care cardiac center, were included in the study. Aborted MI was defined as the spontaneous resolution of ST-segment elevation by >70% on consecutive ECGs before the administration of definitive reperfusion therapy. Patients were categorized into two groups: reperfusion therapy (RT) and recanalized vessels (RV) group. The RT group included patients who underwent plain old balloon angioplasty (POBA) or stent deployment. Results: Among the 120 patients, 85.8% (103) were male, with a mean age of 48.91±11.62 years. Recanalized vessels were observed in 36.7% (44) of the patients. Compared to the RT group, patients in the RV group were relatively younger (43.41±12.68 vs. 52.09±9.7 years; p<0.001). A significantly higher proportion of patients in the RV group had anterior wall MI (AWMI) (67.1% vs. 9.5%; p<0.001) and a shorter median chest pain-to-ACS protocol time (180 [120-255] vs. 300 [180-360] minutes; p=0.003). Multivariable regression analysis identified AWMI as an independent predictor of the need for immediate revascularization, with an adjusted odds ratio of 5.74 [95% CI: 2.33-14.16]. Conclusion: Our study concludes that patients with aborted MI can be classified based on their clinical profiles to determine the timing and strategy of revascularization. Patients were categorized into two groups: those with recanalized vessels (RV) on angiography and those requiring revascularization therapy (RT), either POBA or stent deployment. Several predictors, such as younger age at presentation, type 2 diabetes mellitus, smoking, family history of premature coronary artery disease, dyslipidemia, and the time elapsed after chest pain onset, can help pre-classify patients into high-risk categories requiring immediate revascularization or low-risk categories eligible for early invasive strategies.
- Open Access
- 15 March 2025
- Published by Ayub Medical College, Abbottabad Pakistan in Journal of Ayub Medical College Abbottabad
- Vol. 37 (1)
THE TIMELESS UTILITY OF DUKE TREADMILL SCORE: A PROGNOSTIC TOOL FOR CORONARY ARTERY DISEASE SEVERITY ASSESSMENT
Background: This cross-sectional study aimed to evaluate the correlation between Duke Treadmill Score (DTS) and SYNTAX score and assess the role of DTS in predicting the severity of coronary artery disease (CAD) in patients with stable ischemic heart diseases. Methods: Conducted at a tertiary care cardiac center, the study included patients presenting to the outpatient department for the first time with angina and a positive exercise tolerance test (ETT), who underwent coronary angiogram. Correlation analysis was performed between DTS and SYNTAX score, and receiver operating characteristic (ROC) curve analysis was conducted for DTS to detect the presence (SYNTAX score ≥0) and severity (SYNTAX score ≥33) of CAD. Results: Out of 303 patients, 72.6% (220) were male, with a mean age of 53.31±10.11 years. CAD was confirmed in 79.9% (242) of patients. The mean SYNTAX score was 18.77±14.18, with 46.5% (141) categorized as low-risk, 27.1% as intermediate-risk, and 26.4% as high-risk. The mean DTS score was -6.09±4.5, with 13.9% categorized as high risk and the remaining 86.1% as intermediate or low risk. The Pearson correlation coefficient between DTS and SYNTAX score was -0.806 (p<0.001). The area under the curve (AUC) for DTS score in detecting the presence and severity of CAD was 0.992 [0.985–0.998] and 0.895 [0.860–0.929], respectively. Conclusion: A strong negative correlation was observed between SYNTAX score and DTS, highlighting the predictive value of DTS for assessing CAD severity. The DTS score demonstrated very high diagnostic accuracy in detecting the presence and severity of CAD.
- 15 March 2025
- Published by Ayub Medical College, Abbottabad Pakistan in Journal of Ayub Medical College Abbottabad
- Vol. 37 (1)
Open AccessTHE TIMELESS UTILITY OF DUKE TREADMILL SCORE: A PROGNOSTIC TOOL FOR CORONARY ARTERY DISEASE SEVERITY ASSESSMENT
Background: This cross-sectional study aimed to evaluate the correlation between Duke Treadmill Score (DTS) and SYNTAX score and assess the role of DTS in predicting the severity of coronary artery disease (CAD) in patients with stable ischemic heart diseases. Methods: Conducted at a tertiary care cardiac center, the study included patients presenting to the outpatient department for the first time with angina and a positive exercise tolerance test (ETT), who underwent coronary angiogram. Correlation analysis was performed between DTS and SYNTAX score, and receiver operating characteristic (ROC) curve analysis was conducted for DTS to detect the presence (SYNTAX score ≥0) and severity (SYNTAX score ≥33) of CAD. Results: Out of 303 patients, 72.6% (220) were male, with a mean age of 53.31±10.11 years. CAD was confirmed in 79.9% (242) of patients. The mean SYNTAX score was 18.77±14.18, with 46.5% (141) categorized as low-risk, 27.1% as intermediate-risk, and 26.4% as high-risk. The mean DTS score was -6.09±4.5, with 13.9% categorized as high risk and the remaining 86.1% as intermediate or low risk. The Pearson correlation coefficient between DTS and SYNTAX score was -0.806 (p<0.001). The area under the curve (AUC) for DTS score in detecting the presence and severity of CAD was 0.992 [0.985–0.998] and 0.895 [0.860–0.929], respectively. Conclusion: A strong negative correlation was observed between SYNTAX score and DTS, highlighting the predictive value of DTS for assessing CAD severity. The DTS score demonstrated very high diagnostic accuracy in detecting the presence and severity of CAD.
- Open Access
Primary prevention of cardiovascular diseases among women in a South Asian population: a descriptive study of modifiable risk factors
Objective: The aim of this study was the assessment of modifiable risk factors of cardiovascular diseases (CVD) among women versus men at a newly developed preventive cardiology clinic of a large tertiary care cardiac centre in Pakistan. Design: Observational study. Setting: Tertiary care cardiac hospital in Karachi, Pakistan. Participants: Data for this study were obtained retrospectively from a prospectively collected ongoing registry. We have included all female and male individuals who have presented or were referred to our clinic for primary prevention. All the participants had no history of ischaemic heart disease. Outcome measure: In this study, we evaluated the CVD risk factors, estimated risk of CVD, and glycaemic and cholesterol control at baseline and at subsequent follow-ups for high-risk patients. Results: A total of 535 patients, 314 females, were included with a mean age of 48.3±12.5 years. At baseline, 57.9% (128) of men versus 73.2% (230) of women (p2 , respectively. Baseline atherosclerotic cardiovascular disease (ASCVD) risk score was available for 348 (65%), 61.5% (136) of men versus 67.5% (212) of women. The median ASCVD risk score was 6.8% (2.8%–16.1%) vs 2.25% (1%–5.1%) (p<0.001 for men and women, respectively). The ASCVD risk score was ≥20% (high risk) for 22.1% (30) vs 1.9% (4), while the ASCVD risk score was <5% (low risk) for 40.4% (55) vs 74.1% (157) of men and women, respectively. A repeat ASCVD assessment at a median follow-up of 49.5 (7.0–231) days was available for 259 (48.4%) patients, 26.2% (58) of men vs 64% (201) of women, respectively. The median follow-up ASCVD score was 6.55% (2.8%–15.4%) vs 2.1% (0.9%–4.8%) (p<0.001 with ≥20% (high risk) in 19% (11) vs 2% (4) and <5% (low risk) in 34.5% (20) vs 77.1% (155) of men and women, respectively). Conclusion(s): There is a high prevalence of modifiable risk factors for atherosclerotic CVD such as HTN, diabetes and obesity in women as compared with men, but interestingly, ASCVD risk score at the baseline as well as at the follow-up is high in men versus women. Some other non-modifiable risk factors like age, gender and blood lipid profile may also contribute to this difference between the high prevalence of risk factors and low ASCVD risk score in women. With appropriate follow-up and proper counselling, the looming CVD can be better prevented in this population. A dedicated preventive cardiology clinic for the identification of high-risk women and systematic follow-up is needed to predict their actual CVD risk. Trial registration: NCT06503341 .
Open AccessPrimary prevention of cardiovascular diseases among women in a South Asian population: a descriptive study of modifiable risk factors
Objective: The aim of this study was the assessment of modifiable risk factors of cardiovascular diseases (CVD) among women versus men at a newly developed preventive cardiology clinic of a large tertiary care cardiac centre in Pakistan. Design: Observational study. Setting: Tertiary care cardiac hospital in Karachi, Pakistan. Participants: Data for this study were obtained retrospectively from a prospectively collected ongoing registry. We have included all female and male individuals who have presented or were referred to our clinic for primary prevention. All the participants had no history of ischaemic heart disease. Outcome measure: In this study, we evaluated the CVD risk factors, estimated risk of CVD, and glycaemic and cholesterol control at baseline and at subsequent follow-ups for high-risk patients. Results: A total of 535 patients, 314 females, were included with a mean age of 48.3±12.5 years. At baseline, 57.9% (128) of men versus 73.2% (230) of women (p2 , respectively. Baseline atherosclerotic cardiovascular disease (ASCVD) risk score was available for 348 (65%), 61.5% (136) of men versus 67.5% (212) of women. The median ASCVD risk score was 6.8% (2.8%–16.1%) vs 2.25% (1%–5.1%) (p<0.001 for men and women, respectively). The ASCVD risk score was ≥20% (high risk) for 22.1% (30) vs 1.9% (4), while the ASCVD risk score was <5% (low risk) for 40.4% (55) vs 74.1% (157) of men and women, respectively. A repeat ASCVD assessment at a median follow-up of 49.5 (7.0–231) days was available for 259 (48.4%) patients, 26.2% (58) of men vs 64% (201) of women, respectively. The median follow-up ASCVD score was 6.55% (2.8%–15.4%) vs 2.1% (0.9%–4.8%) (p<0.001 with ≥20% (high risk) in 19% (11) vs 2% (4) and <5% (low risk) in 34.5% (20) vs 77.1% (155) of men and women, respectively). Conclusion(s): There is a high prevalence of modifiable risk factors for atherosclerotic CVD such as HTN, diabetes and obesity in women as compared with men, but interestingly, ASCVD risk score at the baseline as well as at the follow-up is high in men versus women. Some other non-modifiable risk factors like age, gender and blood lipid profile may also contribute to this difference between the high prevalence of risk factors and low ASCVD risk score in women. With appropriate follow-up and proper counselling, the looming CVD can be better prevented in this population. A dedicated preventive cardiology clinic for the identification of high-risk women and systematic follow-up is needed to predict their actual CVD risk. Trial registration: NCT06503341 .
- Open Access
- 6 January 2023
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2023, 1-6
Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization
Background. Distal embolization due to microthrombus fragments formed during predilation ballooning is considered one of the possible mechanisms of slow flow/no-reflow (SF/NR). Therefore, this study aimed to compare the incidence of intraprocedure SF/NR during the primary percutaneous coronary intervention (PCI) in patients with high thrombus burden (≥4 grade) with and without predilation ballooning for culprit lesion preparation. Methodology. This prospective descriptive cross-sectional study included patients with a high thrombus burden (≥4 grades) who underwent primary PCI. Propensity-matched cohorts of patients with and without predilation ballooning in a 1 : 1 ratio were compared for the incidence of intraprocedure SF/NR. Results. A total of 765 patients with high thrombus burden undergoing primary PCI were included in this study. The mean age was 55.75 ± 11.54 years, and 78.6% (601) were males. Predilation ballooning was conducted in 346 (45.2%) patients. The incidence of intraprocedure SF/NR was significantly higher (41.3% vs. 27.4%; ) in patients with predilation ballooning than in those without preballooning, respectively. The incidence of intraprocedure SF/NR also remained significantly higher for the predilation ballooning cohort with an incidence rate of 41.3% as against 30.1% ( ) for the propensity-matched cohort of patients without predilation ballooning with a relative risk of 1.64 (95% CI: 1.20 to 2.24). Moreover, the in-hospital mortality rate remained higher but insignificant, among patients with and without predilation ballooning (8.1% vs. 4.9%; ). Conclusion. In conclusion, predilation ballooning can be associated with an increased risk of incidence of intraprocedure SF/NR during primary PCI in patients with high thrombus burden.
- 6 January 2023
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2023, 1-6
Open AccessPredilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization
Background. Distal embolization due to microthrombus fragments formed during predilation ballooning is considered one of the possible mechanisms of slow flow/no-reflow (SF/NR). Therefore, this study aimed to compare the incidence of intraprocedure SF/NR during the primary percutaneous coronary intervention (PCI) in patients with high thrombus burden (≥4 grade) with and without predilation ballooning for culprit lesion preparation. Methodology. This prospective descriptive cross-sectional study included patients with a high thrombus burden (≥4 grades) who underwent primary PCI. Propensity-matched cohorts of patients with and without predilation ballooning in a 1 : 1 ratio were compared for the incidence of intraprocedure SF/NR. Results. A total of 765 patients with high thrombus burden undergoing primary PCI were included in this study. The mean age was 55.75 ± 11.54 years, and 78.6% (601) were males. Predilation ballooning was conducted in 346 (45.2%) patients. The incidence of intraprocedure SF/NR was significantly higher (41.3% vs. 27.4%; ) in patients with predilation ballooning than in those without preballooning, respectively. The incidence of intraprocedure SF/NR also remained significantly higher for the predilation ballooning cohort with an incidence rate of 41.3% as against 30.1% ( ) for the propensity-matched cohort of patients without predilation ballooning with a relative risk of 1.64 (95% CI: 1.20 to 2.24). Moreover, the in-hospital mortality rate remained higher but insignificant, among patients with and without predilation ballooning (8.1% vs. 4.9%; ). Conclusion. In conclusion, predilation ballooning can be associated with an increased risk of incidence of intraprocedure SF/NR during primary PCI in patients with high thrombus burden.
- Open Access
- 30 March 2022
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 17 (1) , 24
Incidence, Predictors, and Outcomes of Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study
Stent thrombosis (ST) remains the most feared complication of percutaneous coronary intervention (PCI). Therefore, this study aimed to determine acute and sub-acute ST incidence, predictors, and outcomes after primary PCI. This prospective observational study included patients who had undergone primary PCI at a tertiary care cardiac center. All the patients were followed at 30-days of index hospitalization for the incidence of acute or sub-acute ST. ST was further categorized as definite, probable, or possible per the Academic Research Consortium definition. All the survivors of ST were followed after 6-months for the incidence of major adverse cardiovascular events. An aggregate of 1756 patients were included with 79% (1388) male patients and mean age was 55.59 ± 11.23 years. The incidence of ST was 4.9% (86) with 1.3% (22) acute and 3.6% (64) sub-acute. ST was categorized as definite in 3.3% (58) and probable in 1.6% (28). Independent predictor of ST were observed to be male gender (odds ratio (OR); 2.51 [1.21–5.2]), left ventricular end-diastolic pressure ≥20 mmHg (OR; 2.55 [1.31–4.98]), and pre-procedure thrombolysis in myocardial infarction (TIMI) flow 0 (OR; 3.27 [1.61–6.65]). Cumulative all-cause mortality among patients with ST after 164.1 ± 76.2 days was 46.5% (40/86). We observed a substantial number of patients vulnerable to the acute or sub-acute ST after primary PCI. Male gender, LVEDP, pre-procedure TIMI flow grade can be used to identify and efficiently manage highly vulnerable patients.
- 30 March 2022
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 17 (1) , 24
Open AccessIncidence, Predictors, and Outcomes of Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study
Stent thrombosis (ST) remains the most feared complication of percutaneous coronary intervention (PCI). Therefore, this study aimed to determine acute and sub-acute ST incidence, predictors, and outcomes after primary PCI. This prospective observational study included patients who had undergone primary PCI at a tertiary care cardiac center. All the patients were followed at 30-days of index hospitalization for the incidence of acute or sub-acute ST. ST was further categorized as definite, probable, or possible per the Academic Research Consortium definition. All the survivors of ST were followed after 6-months for the incidence of major adverse cardiovascular events. An aggregate of 1756 patients were included with 79% (1388) male patients and mean age was 55.59 ± 11.23 years. The incidence of ST was 4.9% (86) with 1.3% (22) acute and 3.6% (64) sub-acute. ST was categorized as definite in 3.3% (58) and probable in 1.6% (28). Independent predictor of ST were observed to be male gender (odds ratio (OR); 2.51 [1.21–5.2]), left ventricular end-diastolic pressure ≥20 mmHg (OR; 2.55 [1.31–4.98]), and pre-procedure thrombolysis in myocardial infarction (TIMI) flow 0 (OR; 3.27 [1.61–6.65]). Cumulative all-cause mortality among patients with ST after 164.1 ± 76.2 days was 46.5% (40/86). We observed a substantial number of patients vulnerable to the acute or sub-acute ST after primary PCI. Male gender, LVEDP, pre-procedure TIMI flow grade can be used to identify and efficiently manage highly vulnerable patients.
- Open Access
- 22 March 2022
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e23383
COVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency
The coronavirus disease 2019 (COVID-19) vaccinations have brought new hope to the world and have a significant psychosocial impact on communities as well as healthcare systems around the globe. This study aimed to assess the antibody titer level among healthcare workers after at least six weeks of the second dose of the COVID-19 vaccine. Participants of the study were healthcare workers of a tertiary care cardiac center including doctors, nursing staff, paramedics, and office staff. All participants were fully vaccinated with recommended double dose of available vaccine at least six weeks before the study. A blood sample of five milliliters was collected from all the participants by a trained phlebotomist at a local laboratory, and COVID-19 antibodies titer level was assessed using Food and Drug Administration (FDA) approved kit with a standard range of 1.0. This qualitative assay detects IgG and IgM as total antibodies targeted against nucleocapsid antigen performed on a fully automated cobas® 6000 analyzer (F. Hoffmann-La Roche Ltd, Basel, Switzerland) using electrochemiluminescence technology. COVID-19 antibodies titer levels were categorized as ≤100, 101-250, and >250. A total of 151 healthcare workers were included, of which 70.2% (106) were male. The history of COVID-19 infection before vaccination was found in 41.1% (62). The mean duration since the last dose of the vaccine was 89.6±40.07 days. In total 71.5% (108) had antibodies titer level of >250, which were mostly found in participants of younger age and who had previous COVID-19 infection. However, antibodies titer level of >250 were observed in 84% (21/25) at 61 to 90 days of vaccination, which declined to 80% (20/25) after 91 to 120 days and to 57.1% (32/56) after >120 days of vaccination. Good antibodies titer levels were observed in vaccinated healthcare workers, especially in those who were younger and had previous COVID-19 infection.
- 22 March 2022
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e23383
Open AccessCOVID-19 Antibodies in Vaccinated Healthcare Workers: The Security Currency
The coronavirus disease 2019 (COVID-19) vaccinations have brought new hope to the world and have a significant psychosocial impact on communities as well as healthcare systems around the globe. This study aimed to assess the antibody titer level among healthcare workers after at least six weeks of the second dose of the COVID-19 vaccine. Participants of the study were healthcare workers of a tertiary care cardiac center including doctors, nursing staff, paramedics, and office staff. All participants were fully vaccinated with recommended double dose of available vaccine at least six weeks before the study. A blood sample of five milliliters was collected from all the participants by a trained phlebotomist at a local laboratory, and COVID-19 antibodies titer level was assessed using Food and Drug Administration (FDA) approved kit with a standard range of 1.0. This qualitative assay detects IgG and IgM as total antibodies targeted against nucleocapsid antigen performed on a fully automated cobas® 6000 analyzer (F. Hoffmann-La Roche Ltd, Basel, Switzerland) using electrochemiluminescence technology. COVID-19 antibodies titer levels were categorized as ≤100, 101-250, and >250. A total of 151 healthcare workers were included, of which 70.2% (106) were male. The history of COVID-19 infection before vaccination was found in 41.1% (62). The mean duration since the last dose of the vaccine was 89.6±40.07 days. In total 71.5% (108) had antibodies titer level of >250, which were mostly found in participants of younger age and who had previous COVID-19 infection. However, antibodies titer level of >250 were observed in 84% (21/25) at 61 to 90 days of vaccination, which declined to 80% (20/25) after 91 to 120 days and to 57.1% (32/56) after >120 days of vaccination. Good antibodies titer levels were observed in vaccinated healthcare workers, especially in those who were younger and had previous COVID-19 infection.
- Open Access
- 1 February 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 15 (2) , 163-171
Comparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial)
Background: Intracoronary epinephrine has been effectively used in treating refractory no-reflow, but there is a dearth of data on its use as a first-line drug in normotensive patients in comparison to the widely used adenosine. Methods: In this open-labeled randomized clinical trial, 201 patients with no-reflow were randomized 1:1 into intracoronary epinephrine as the treatment group and intracoronary adenosine as the control group and followed for 1 month. The primary end points were improvement in coronary flow, as assessed by TIMI (Thrombolysis in Myocardial Infarction) flow, frame counts, and myocardial blush. Secondary end points were in-hospital and short-term mortality and major adverse cardiac events. Results: In all, 101 patients received intracoronary epinephrine and 100 patients received adenosine. Epinephrine was generally well tolerated with no immediate table death or ventricular fibrillation. No-reflow was more effectively improved with epinephrine with final TIMI III flow (90.1% versus 78%, P =0.019) and final corrected TIMI frame count (24±8.43 versus 26.63±9.22, P =0.036). However, no significant difference was observed in final grade III myocardial blush (55.4% versus 45%, P =0.139), mean reduction of corrected TIMI frame count (−25.71±11.79 versus −26.08±11.71, P =0.825), in-hospital and short-term mortality, and major adverse cardiac events. Conclusions: Epinephrine is relatively safe to use in no-reflow in normotensive patients. A significantly higher frequency of post-treatment TIMI III flow grade and lower final corrected TIMI frame count with relatively better achievement of myocardial blush grade III translate into it displaying relatively better efficacy than adenosine. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04699110.
- 1 February 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 15 (2) , 163-171
Open AccessComparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial)
Background: Intracoronary epinephrine has been effectively used in treating refractory no-reflow, but there is a dearth of data on its use as a first-line drug in normotensive patients in comparison to the widely used adenosine. Methods: In this open-labeled randomized clinical trial, 201 patients with no-reflow were randomized 1:1 into intracoronary epinephrine as the treatment group and intracoronary adenosine as the control group and followed for 1 month. The primary end points were improvement in coronary flow, as assessed by TIMI (Thrombolysis in Myocardial Infarction) flow, frame counts, and myocardial blush. Secondary end points were in-hospital and short-term mortality and major adverse cardiac events. Results: In all, 101 patients received intracoronary epinephrine and 100 patients received adenosine. Epinephrine was generally well tolerated with no immediate table death or ventricular fibrillation. No-reflow was more effectively improved with epinephrine with final TIMI III flow (90.1% versus 78%, P =0.019) and final corrected TIMI frame count (24±8.43 versus 26.63±9.22, P =0.036). However, no significant difference was observed in final grade III myocardial blush (55.4% versus 45%, P =0.139), mean reduction of corrected TIMI frame count (−25.71±11.79 versus −26.08±11.71, P =0.825), in-hospital and short-term mortality, and major adverse cardiac events. Conclusions: Epinephrine is relatively safe to use in no-reflow in normotensive patients. A significantly higher frequency of post-treatment TIMI III flow grade and lower final corrected TIMI frame count with relatively better achievement of myocardial blush grade III translate into it displaying relatively better efficacy than adenosine. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04699110.